Nucleic Acid–Based Therapeutics for Parkinson’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nucleic Acid–Based Therapeutics for Parkinson’s Disease

Published:2019-02-12 Issue:2 Volume:16 Page:287-298
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Nakamori Masayuki,Junn Eunsung,Mochizuki Hideki,Mouradian M. Maral^ORCID

Funder

National Institute of Neurological Disorders and Stroke

National Center for Complementary and Alternative Medicine

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Clinical Neurology,Pharmacology

Link

http://link.springer.com/article/10.1007/s13311-019-00714-7/fulltext.html

Reference75 articles.

1. Titova N, Qamar MA, Chaudhuri KR. The Nonmotor Features of Parkinson’s Disease. Int Rev Neurobiol 2017; 132: 33–54.

2. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003; 24: 197–211.

3. Yasuda T, Mochizuki H. The regulatory role of alpha-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease. Apoptosis 2010; 15: 1312–1321.

4. Hayashita-Kinoh H, Yamada M, Yokota T, Mizuno Y, Mochizuki H. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson’s disease rat model. Biochem Biophys Res Commun 2006; 341: 1088–1095.

5. Sapru MK, Yates JW, Hogan S, Jiang L, Halter J, Bohn MC. Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi. Exp Neurol 2006; 198: 382–390.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective lowering of α-synuclein expression by targeting G-quadruplex structures within the SNCA gene;International Journal of Biological Macromolecules;2024-10

2. Therapeutic nucleic acids in regenerative medicine and tissue repair;Nano Research;2024-07-13

3. In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-22

4. Pharmacotherapy for Disease Modification in Early Parkinson’s Disease: How Early Should We Be?;Journal of Parkinson's Disease;2024-02-29

5. Effective lowering of α-synuclein expression by targeting G-quadruplex structures within the SNCA gene;2024-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3